Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates

Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates

Substantial interassay variability (up to 20%) has been described for vancomycin immunoassays in adults, but the impact of neonatal matrix is difficult to quantify because of blood volume constraints in neonates. However, we provide circumstantial evidence for a similar extent of variability. Using...

Full description

Bibliographic Details
Main Authors:	Janko Samardzic, Anne Smits, Isabel Spriet, Ivan Soldatovic, Andrew Atkinson, Milica Bajcetic, John N. Van Den Anker, Karel Allegaert
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2016/1974972

Similar Items

Amikacin or Vancomycin Exposure Alters the Postnatal Serum Creatinine Dynamics in Extreme Low Birth Weight Neonates
by: Tamara van Donge, et al.
Published: (2021-01-01)

Clinical pharmacokinetics of vancomycin in the neonate: a review
by: Gian Maria Pacifici, et al.
Published: (2012-07-01)

Vancomycin trough level and loading dose
by: Tuon FF, et al.
Published: (2018-11-01)

Prospective validation of neonatal vancomycin dosing regimens is urgently needed
by: Anaïs Vandendriessche, MD, et al.
Published: (2014-12-01)

Validation of a immunoassay for the determination of vancomycin in cerebospinal fluid.
by: Lucrecia Marks, et al.
Published: (2019-06-01)

Trough Concentrations of Vancomycin in Patients Undergoing Extracorporeal Membrane Oxygenation.
by: So Jin Park, et al.
Published: (2015-01-01)

Predictability of Vancomycin Trough Concentrations Using Five Predictive Methods
by: Gowler, Aimee, et al.
Published: (2011)

An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients
by: Huang X, et al.
Published: (2021-04-01)

Effects of staff education and standardizing dosing and collection times on vancomycin trough appropriateness in ward patients
by: Hammond DA, et al.
Published: (2017-06-01)

Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality
by: Alshehri N, et al.
Published: (2020-10-01)

Serum trough level as a postmarketing quality measure of generic vancomycin products
by: Ya-Wen Tsai, et al.
Published: (2020-04-01)

Prospective Trial of a Novel Nomogram to Achieve Updated Vancomycin Trough Concentrations
by: Amber R. Wesner, et al.
Published: (2013-01-01)

Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit
by: Xiaodan Qian, et al.
Published: (2017-07-01)

Population pharmacokinetics and dose optimization of vancomycin in neonates
by: Soon Min Lee, et al.
Published: (2021-03-01)

Evaluation of vancomycin initial trough levels in children: A 1-year retrospective study
by: Muhammad Salem, et al.
Published: (2020-08-01)

Comparison of the trough levels of two vancomycin formulations in a selected preterm infant population
by: Griesel, H.A
Published: (2015)

Eradication of Vancomycin-Resistant Enterococci by Combining Phage and Vancomycin
by: Mor Shlezinger, et al.
Published: (2019-10-01)

Sequestration of Voriconazole and Vancomycin Into Contemporary Extracorporeal Membrane Oxygenation Circuits: An in vitro Study
by: Genny Raffaeli, et al.
Published: (2020-08-01)

The effect of body mass index and creatinine clearance on serum trough concentration of vancomycin in adult patients
by: Yuyan Pan, et al.
Published: (2020-05-01)

Vancomycin use, dosing and serum trough concentrations in the pediatric population: a retrospective institutional review.
by: Rajon K, et al.
Published: (2017-06-01)

Characterizing Vancomycin-resistant Enterococci in Neonatal Intensive Care
by: C. Rebecca Sherer, et al.
Published: (2005-09-01)

Investigation of the Vancomycin-Affected Proteins in Vancomycin-Resistant Staphylococcus aureus
by: Wei Ting Jiang, et al.
Published: (2008)

Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates
by: Stéphanie Leroux, et al.
Published: (2021-03-01)

Vancomycin-resistant Enterococcus faecalis in Serbia
by: Branka Stošović, et al.
Published: (2004-01-01)

Vancomycin-induced nephrotoxicity with unusual high serum trough level in a critically ill young patient
by: Yi Xin Cheng, et al.
Published: (2016-01-01)

The impact of vancomycin trough concentrations on outcomes in non-deep seated infections: a retrospective cohort study
by: Michael Wan, et al.
Published: (2018-07-01)

The Relationship between Vancomycin Serum Trough Concentration and Clinical Outcome and Nephrotoxicity in Hospitalized Adults with ORSA Bacteremia
by: Chun-Nan Kuo, et al.
Published: (2006)

Empiric Vancomycin Dosing in Pediatric Patients with Congenital Heart Disease and the Impact of Cardiopulmonary Bypass on Trough Concentrations
by: Picone, Amy
Published: (2018)

Vancomycin-Lipopeptide Conjugates with High Antimicrobial Activity on Vancomycin-Resistant Enterococci
by: Eric Mühlberg, et al.
Published: (2020-05-01)

Molecular characterization of virulence genes in vancomycin-resistant and vancomycin-sensitive enterococci
by: Priyanka Paul Biswas, et al.
Published: (2016-01-01)

Molecular events for promotion of vancomycin resistance in vancomycin intermediate Staphylococcus aureus
by: Qiwen Hu, et al.
Published: (2016-10-01)

Investigation of the effect of vancomycin on biofilm formation in vancomycin-resistant Staphylococcus aureus
by: Yi Hsiang Cheng, et al.
Published: (2009)

Laboratory correlation between vancomycin levels and serum creatinine in the nephrotoxicity of vancomycin
by: Luiza K.R.P. Araújo, et al.
Published: (2016-12-01)

Creatinine Trends to Detect Ibuprofen-Related Maturational Adverse Drug Events in Neonatal Life: A Simulation Study for the ELBW Newborn
by: Tamara van Donge, et al.
Published: (2021-01-01)

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate
by: Jeong Eun Shin, et al.
Published: (2015-11-01)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
by: Mwila Mulubwa, et al.
Published: (2020-04-01)

Target Attainment and Clinical Efficacy for Vancomycin in Neonates: Systematic Review
by: Marta Mejías-Trueba, et al.
Published: (2021-03-01)

Vancomycin Resistant Enterococcus
by: Mehveen Iqbal, et al.
Published: (2019-05-01)

The Role of Vancomycin on Meningitis
by: Ahmed I. Shatat and P.I.C.U team, et al.
Published: (2014-06-01)

Structural Studies on Vancomycin
by: Smith, K. A.
Published: (1974)